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LETTERS
although its mechanism of action 
against HCV and HEV is uncertain. 
Data are limited on the use of ribavi-
rin in patients with chronic hepatitis E 
and hematologic malignancies (10). 
The outcome for our patient suggests 
that ribavirin might be useful for treat-
ing hepatitis E in such patients.
In conclusion, all patients with 
hepatitis of unknown origin should be 
tested for HEV, in particular, immuno-
compromised patients, because they 
are at risk of acquiring chronic hepa-
titis and having an adverse outcome. 
Ribavirin appears to be efficacious in 
treating hepatitis E and should be con-
sidered for any immunocompromised 
person who has viremia 3 months after 
acute infection.
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Q Fever  
Surveillance  
in Ruminants,  
Thailand, 2012
To the Editor: Two cases of fatal 
endocarditis in Khon Kaen Province 
in northeastern Thailand were found 
to be caused by Coxiella burnetii (1). 
Although C. burnetii is known to be 
present in many countries, including in 
Thailand (2), human infection is more 
commonly associated with sheep and 
goats, possibly because these animals 
shed the organism more frequently in 
vaginal secretions and feces than do 
large ruminants (3).
Surveillance for Q fever, which is 
caused by C. burnetii, in livestock is 
currently based primarily on serologic 
or PCR testing of milk (4). However, 
problems in estimating prevalence 
include serologic assay insensitivity 
(5,6) or unavailability of milk from 
nondairy animals.
For diagnosis of Q fever, the 
placenta of the animal is commonly 
tested, but testing is usually conducted 
only when abortions occur, which is 
only likely when uninfected animals 
first encounter C. burnetii. There-
fore, this approach might underesti-
mate true organism distribution in a 
disease-endemic area (7). In addition, 
nearly all abortion storms have oc-
curred in sheep or goats, which are 
rare in Thailand. Ruminant abortion is 
rarely reported to veterinary authori-
ties in Thailand.
Comparison of paired colostrum 
and placental samples from sheep 
showed that C. burnetii was found 
more frequently in placental samples 
(8), which suggested that the placenta 
is a better sample than milk for sur-
veillance purposes. Also, a placenta 
may be more useful because it is 
more likely to contaminate the farm 
environment. Milk is an unlikely 
source of Q fever in adult persons be-
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The ideal surveillance strategy 
would include all relevant samples 
(serum, milk, and products of con-
ception, both normal and abnormal). 
However, in practice, cost and logis-
tical limitations dictate refinement of 
sampling. C. burnetii is frequently de-
tected in normal ruminant placentas, 
but offspring are apparently not af-
fected (9). We report that surveillance 
of normal placentas can provide useful 
surveillance data.
To test this hypothesis, in 2012 
we asked local veterinarians in se-
lected subdistricts in Thailand to 
contact farmers at their convenience 
to request that the veterinarians be 
alerted when a ruminant gave birth. 
Only grossly normal placentae from 
normal births of apparently healthy 
offspring were sampled. Cotyledon-
ary (preferred) or intercotyledonary 
chorioallantoic tissue was obtained, 
chilled, and shipped cold to the Na-
tional Institute for Animal health 
(Bangkok, Thailand) for analysis. 
Tissue was ground, extracted, and 
analyzed by PCR for IS1111 of C. 
burnetii in a Light Cycler 2.0 Appa-
ratus (Roche, Basel, Switzerland) as 
described (10). To minimize false-
positive results, we repeated the PCR 
with a separate portion of tissue from 
the original sample. Samples were 
considered positive if the PCR had a 
cycle threshold <35 for each assay, or 
suspected of being positive if this oc-
curred in 1 of 2 separate assays.
Results indicate a high frequency 
of C. burnetii infections in some prov-
inces (Table), which roughly match 
locations where fatal human cases 
of endocarditis have occurred (Fig-
ure, Appendix, wwwnc.cdc.gov/EID/
article/19/12/13-0624-F1.htm). It is 
common practice among the agrarian 
population in Thailand to consume ru-
minant placenta. Although this tissue is 
reportedly cooked before consumption, 
the preparation process may result in 
environmental contamination sufficient 
to expose persons who were not in 
close contact with the infected animal.
This study demonstrates that sam-
pling and PCR of grossly normal ru-
minant placenta is a viable stand-alone 
approach for surveillance of C. bur-
netii that might enable the generation, 
at a minimal cost, of a highly detailed 
map showing areas where humans and 
animals are at risk for Q fever. The re-
sults indicate that C. burnetii is highly 
endemic in the study region. However, 
in light of the extreme rarity of serious 
complications in human infections and 
lack of any indication of a serious ef-
fect on animal production, these results 
do not indicate a need for veterinary 
control measures. Nonetheless, food 
safety practices should be addressed. 
It is essential that physicians monitor-
ing patients with underlying heart valve 
conditions encourage such patients to 
seek diagnosis of any febrile illness so 
that appropriate treatment may be initi-
ated to minimize risk for complications.
We report a novel approach to 
Q fever surveillance, which is po-
tentially useful for countries such as 
Thailand, where subclinical ruminant 
infections are common. Our results 
also provide an initial indication of 
risk factors associated with recent 
cases of fatal Q fever endocarditis in 
Thailand. Follow-up research should 
include broader reservoir species sur-
veillance, environmental surveillance, 
and comparison of genotypes of or-
ganisms found in ruminant placenta 
with those found in persons with en-
docarditis. These further efforts will 
result in clearer understanding of Q 
fever ecology and potential routes of 
human exposure.
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Positive Negative Suspected	 
Chaiyapum	(13) Beef	cattle 3 10 0 
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Prachuap	Kiri	Khan	(9) Dairy	cattle 3 1 6 
Ratchaburi	(2) Goat 1 9 0 
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Treponemal  
Infection in  
Nonhuman  
Primates as  
Possible Reservoir 
for Human Yaws
To the Editor: In 2012, the 
World Health Organization launched 
plans for a second campaign to eradi-
cate the neglected tropical disease, 
yaws (1). The first campaign, con-
ducted during the mid-20th century, 
was tremendously successful in terms 
of treatment and reduced the number 
of cases by 95%. However, it failed to 
eradicate the disease, and when local 
efforts to prevent new cases proved 
insufficient, yaws resurged in some 
areas. Comments on the new yaws 
eradication campaign have empha-
sized the need for sustained support 
and resources. Here we draw attention 
to an additional concern that could im-
pede yaws eradication efforts.
The success of any eradication 
campaign depends on the absence of a 
nonhuman reservoir. Smallpox had no 
known animal reservoir, and polio and 
dracunculiasis (guinea worm disease), 
which are currently the focus of the 
World Health Organization eradication 
campaigns, also have none. By con-
trast, compelling evidence suggests that 
yaws exists in wild nonhuman primate 
populations residing in regions where 
humans are also infected (Figure).
The subspecies of the bacterium 
Treponema pallidum that cause the 
non–sexually transmitted diseases 
yaws (subsp. pertenue infection) and 
endemic syphilis (subsp. endemicum 
infection) and the sexually transmitted 
infection syphilis (subsp. pallidum) 
are close relatives. The 3 diseases 
cannot be distinguished serologically. 
Instead, the diseases they cause are 
usually differentiated by clinical char-
acteristics and geographic distribu-
tion. Whereas syphilis is a venereal 
disease with a worldwide distribution, 
yaws primarily affects children in hot 
and humid areas of Africa and Asia, 
and endemic syphilis occurs in arid 
regions. Because methods available 
to differentiate between the T. pal-
lidum subspecies were unavailable 
in the past, prevalence data for yaws 
were sometimes vague and inaccurate. 
Recently, molecular tests capable of 
distinguishing between the subspecies 
by using single nucleotide polymor-
phisms have been developed (2,3). 
These tests have enabled us to learn 
more about the T. pallidum strains that 
infect wild nonhuman primates.
During the 1960s, researchers re-
ported that many baboons in West Af-
rica were seropositive for treponemal 
infection (4). Since then, high levels 
of infection have been documented in 
other monkey species in West Africa 
and in great apes (5). Recently, we 
documented T. pallidum infection in 
olive baboons (Papio anubis) at Lake 
Manyara National Park in Tanzania 
(6). In West Africa, clinical signs of 
infection in nonhuman primates are 
usually mild, if present at all, con-
sisting of small lesions around the 
muzzle, eyelids, and armpits (4). A 
recent survey in 2013 at Parc National 
du Niokolo-Koba, Senegal, revealed 
T. pallidum antibodies in Guinea ba-
boons (P. papio) with no signs of in-
fection (S. Knauf et al, unpub. data). 
By contrast, severe manifestations 
resembling tertiary-stage yaws have 
been reported in wild gorillas (5). In 
terms of genetic distance, studies thus 
far indicate that the organisms infect-
ing baboons in West and East Africa 
closely resemble T. pallidum subsp. 
pertenue, the agent responsible for 
yaws in humans (2,7). In fact, the ge-
nome sequence of a T. pallidum strain 
collected from a baboon in Guinea 
indicates that it should be considered 
a T. pallidum subsp. pertenue strain 
(8). Infection has been confirmed by 
serologic tests in a variety of nonhu-
man primate species in the yaws belt 
of Africa and by PCR in baboons from 
East and West Africa (Figure).
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